Comments on CboeBZX Rulemaking

Self-Regulatory Organizations; Cboe BZX Exchange, Inc.; Notice of Filing of a Proposed Rule Change to Exempt Closed-End Management Investment Companies Registered Under the Investment Company Act of 1940 that are Listed as of or after May 20, 2025 from the Annual Meeting of Shareholders Requirement Set Forth in Exchange Rule 14.10(f)

Comments have been received from individuals and entities using a variety of Letter Types:

Comment
(SR-CboeBZX-2025-072 form letter A; SR-NYSE-2025-20 form letter B): 574 (SR-CboeBZX-2025-072 form letter A; SR-NYSE-205-20 form letter B)

Filter comments

Date Received
Date Letter Type Commenter Name
Public Comment Michael D'Angelo, Chief Operating Officer and General Counsel, Saba Capital Management, L.P.
Public Comment Paul G. Cellupica, General Counsel, and Kevin Ercoline, Assistant General Counsel, Investment Company Institute
Public Comment Members of Congress, Ann Wagner, Chair, Subcommittee on Capital Markets, Andrew Garbarino, Vice Chair, Subcommittee on Capital Markets, Zach Nunn, Dan Meuser, Marlin Stutzman, Bill Huizenga, Warren Davidson, Michael V. Lawler, Mike Haridopolos, Troy Downing, and Bryan Steil
Public Comment David Schachter
Meeting with SEC Officials Memorandum from the Division of Trading and Markets regarding a September 5, 2025 meeting with representatives of the Investment Company Institute ("ICI")
Public Comment Christopher R Marco
Public Comment Frankie Mossa, Individual Investor
Meeting with SEC Officials Memorandum from the Division of Investment Management regarding a July 23, 2025 meeting with representatives of Saba Capital Management, L.P. ("Saba")
Meeting with SEC Officials Memorandum from the Division of Trading and Markets regarding a July 23, 2025 meeting with representatives of Saba Capital Management, L.P.
Public Comment Terry Ernst
Public Comment Kim Gutschick
Public Comment Mark Jarax
Public Comment Alec Destry
Public Comment Donald VanPatten, Individual Investor
Public Comment Augdon Sampa
Public Comment David Young
Public Comment Mark Steven Gordon, Medical Doctor
Meeting with SEC Officials Memorandum from the Office of the Investor Advocate regarding a July 23, 2025 meeting with representatives and certain members of the Investment Company Institute
Public Comment Jonathan Leigh
Public Comment Tim Fischer
Public Comment Anonymous
Public Comment Dan Guttell
Public Comment Daniel K. Norman
Public Comment David Pertz
Public Comment Devin Hanrahan
Public Comment Gayle Ehrlich
Public Comment Howard L. Barnstone
Public Comment John D. Stacey
Public Comment Michael Hill
Public Comment Muhammed Al-Fawakhiri

Last Reviewed or Updated: Dec. 18, 2025

File Number
SR-CboeBZX-2025-072
Release Number
34-103166
Related Materials
How to submit comments